Bio-company Eyenovia launches HYPE treasury reserve strategy to invest $50 million
2025-06-17 19:12:52
Eyenovia, a clinical-stage ophthalmic biopharmaceutical company, has announced that it will invest $50 million to launch its Hyperliquid (HYPE) treasury reserve strategy.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
US stock Eyenovia rose more than 150%Next article：
超2万个比特币地址持仓价值超1000万美元，占BTC总供应量近9.43%
